Brief: iTeos Therapeutics's Unit Got Upfront Payment Of $625 Mln From Glaxosmithkline Intellectual Property Limited
10/08/2021 12:17
Aug 10 (Reuters) - GlaxoSmithKline PLC GSK.L :
* ITEOS THERAPEUTICS - ON AUG 6, ITEOS BELGIUM, CO'S UNIT
GOT
UPFRONT PAYMENT OF $625 MILLION FROM GLAXOSMITHKLINE
INTELLECTUAL PROPERTY LIMITED
* ITEOS THERAPEUTICS - CO'S UNIT RECEIVED UPFRONT PAYMENT
PURSUANT
TO COLLABORATION AND LICENSE AGREEMENT WITH GLAXOSMITHKLINE
INTELLECTUAL PROPERTY
* ITEOS THERAPEUTICS - FOLLOWING RECEIPT OF UPFRONT PAYMENT,
CO
BELIEVES EXISTING CASH, CASH EQUIVALENTS ENABLE TO FUND
OPERATING, CAPITAL EXPENDITURE REQUIREMENTS INTO 2026
Source text for Eikon: [https://bit.ly/3yAHsvf]
Further company coverage: GSK.L
((Reuters.Briefs@thomsonreuters.com;))
Recent news on iTeos Therapeutics
See all newsIteos Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Iteos Therapeutics Inc expected to post a loss of $1.01 a share - Earnings Preview
Brief: Iteos Therapeutics Enters Into Agreement To Be Acquired By Concentra Biosciences For $10.047 In Cash Per Share Plus A Contingent Value Right
U.S. STOCKS ON THE MOVE-Nvidia, Salesforce, Kestrel Group
U.S. STOCKS ON THE MOVE-Dick's Sporting Goods, Sonic Automotive